Author:
Nauck M. A.,Kleine N.,�rskov C.,Holst J. J.,Willms B.,Creutzfeldt W.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference13 articles.
1. Eissele R, Göke R, Willemer S et al. (1992) Glucagon-like peptide 1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22: 283?291
2. Kreymann B, Ghatei MA, Williams G, Bloom SR (1987) Glucagon-like peptide 1 7?36: a physiological incretin in man. Lancet II: 1300?1304
3. Nauck M, Bartels E, Ørskov C, Ebert R, Creutzfeldt W (1993) Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 (7-36 amide) infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab 76: 912?917
4. Nauck MA, Heimesaat MM, Ørskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide 1 (GLP-1) (7-36 amide) but not of synthetic human gastric inhibitory polypeptide (GIP) in patients with Type 2 diabetes mellitus. J Clin Invest 91: 301?307
5. Nathan DM, Schreiber E, Fogel H, Mojsov S, Habener JF (1992) Insulinotropic action of glucagon-like peptide-I-(7-36) in diabetic and nondiabetic subjects. Diabetes Care 15: 270?276
Cited by
1004 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献